145 related articles for article (PubMed ID: 31497995)
1. Evaluation of a 10color protocol as part of a 2tube screening panel for flow cytometric assessment of peripheral blood leukocytic subsets.
Gounari E; Tsavdaridou V; Ioakeimidou A; Haidich AB; Skoura L
Scand J Clin Lab Invest; 2019 Nov; 79(7):475-483. PubMed ID: 31497995
[TBL] [Abstract][Full Text] [Related]
2. Fluorescence-intensity multiplexing: simultaneous seven-marker, two-color immunophenotyping using flow cytometry.
Bradford JA; Buller G; Suter M; Ignatius M; Beechem JM
Cytometry A; 2004 Oct; 61(2):142-52. PubMed ID: 15382027
[TBL] [Abstract][Full Text] [Related]
3. Optimal number of reagents required to evaluate hematolymphoid neoplasias: results of an international consensus meeting.
Braylan RC; Orfao A; Borowitz MJ; Davis BH
Cytometry; 2001 Feb; 46(1):23-7. PubMed ID: 11241503
[TBL] [Abstract][Full Text] [Related]
4. Polychromatic (eight-color) slide-based cytometry for the phenotyping of leukocyte, NK, and NKT subsets.
Mittag A; Lenz D; Gerstner AO; Sack U; Steinbrecher M; Koksch M; Raffael A; Bocsi J; Tárnok A
Cytometry A; 2005 Jun; 65(2):103-15. PubMed ID: 15830380
[TBL] [Abstract][Full Text] [Related]
5. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y
Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
[TBL] [Abstract][Full Text] [Related]
6. Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation.
Sánchez ML; Almeida J; Vidriales B; López-Berges MC; García-Marcos MA; Moro MJ; Corrales A; Calmuntia MJ; San Miguel JF; Orfao A
Leukemia; 2002 Aug; 16(8):1460-9. PubMed ID: 12145686
[TBL] [Abstract][Full Text] [Related]
7. A combination of CD15/CD10, CD64/CD33, CD16/CD13 or CD11b flow cytometric granulocyte panels is sensitive and specific for diagnosis of myelodysplastic syndrome.
Chung JW; Park CJ; Cha CH; Cho YU; Jang S; Chi HS; Seo EJ; Lee JH; Lee JH; Lee KH; Im HJ; Seo JJ
Ann Clin Lab Sci; 2012; 42(3):271-80. PubMed ID: 22964615
[TBL] [Abstract][Full Text] [Related]
8. Optimized quantification of lymphocyte subsets by use of CD7 and CD33.
Hauser A; Schrattbauer K; Najdanovic D; Schlossnickel R; Koch A; Hejtman M; Krugluger W
Cytometry A; 2013 Mar; 83(3):316-23. PubMed ID: 23315982
[TBL] [Abstract][Full Text] [Related]
9. Rapid single-step method for flow cytometric detection of surface and intracellular antigens using whole blood.
Francis C; Connelly MC
Cytometry; 1996 Sep; 25(1):58-70. PubMed ID: 8875055
[TBL] [Abstract][Full Text] [Related]
10. BIOMED-I concerted action report: flow cytometric immunophenotyping of precursor B-ALL with standardized triple-stainings. BIOMED-1 Concerted Action Investigation of Minimal Residual Disease in Acute Leukemia: International Standardization and Clinical Evaluation.
Lucio P; Gaipa G; van Lochem EG; van Wering ER; Porwit-MacDonald A; Faria T; Bjorklund E; Biondi A; van den Beemd MW; Baars E; Vidriales B; Parreira A; van Dongen JJ; San Miguel JF; Orfao A;
Leukemia; 2001 Aug; 15(8):1185-92. PubMed ID: 11480560
[TBL] [Abstract][Full Text] [Related]
11. Comparative analysis of whole blood lysis methods for flow cytometry.
Bossuyt X; Marti GE; Fleisher TA
Cytometry; 1997 Jun; 30(3):124-33. PubMed ID: 9222098
[TBL] [Abstract][Full Text] [Related]
12. Flow cytometric assessment of human MIC2 expression in bone marrow, thymus, and peripheral blood.
Dworzak MN; Fritsch G; Buchinger P; Fleischer C; Printz D; Zellner A; Schöllhammer A; Steiner G; Ambros PF; Gadner H
Blood; 1994 Jan; 83(2):415-25. PubMed ID: 7506950
[TBL] [Abstract][Full Text] [Related]
13. Clinical application of four and five-color flow cytometry lymphocyte subset immunophenotyping.
Alamo AL; Melnick SJ
Cytometry; 2000 Dec; 42(6):363-70. PubMed ID: 11135290
[TBL] [Abstract][Full Text] [Related]
14. Expression of an early myelopoietic antigen (CD33) on a subset of human umbilical cord blood-derived natural killer cells.
Handgretinger R; Schäfer HJ; Baur F; Frank D; Ottenlinger C; Bühring HJ; Niethammer D
Immunol Lett; 1993 Aug; 37(2-3):223-8. PubMed ID: 7505004
[TBL] [Abstract][Full Text] [Related]
15. A new sensitive and specific combination of CD81/CD56/CD45 monoclonal antibodies for detecting circulating neuroblastoma cells in peripheral blood using flow cytometry.
Nagai J; Ishida Y; Koga N; Tanaka Y; Ohnuma K; Toyoda Y; Katoh A; Hayabuchi Y; Kigasawa H
J Pediatr Hematol Oncol; 2000; 22(1):20-6. PubMed ID: 10695817
[TBL] [Abstract][Full Text] [Related]
16. Flow cytometric characterization of human umbilical cord blood lymphocytes: immunophenotypic features.
D'Arena G; Musto P; Cascavilla N; Di Giorgio G; Fusilli S; Zendoli F; Carotenuto M
Haematologica; 1998 Mar; 83(3):197-203. PubMed ID: 9573672
[TBL] [Abstract][Full Text] [Related]
17. Use of human leukocyte-specific monoclonal antibodies for clinically immunophenotyping lymphocytes of rhesus monkeys.
Reimann KA; Waite BC; Lee-Parritz DE; Lin W; Uchanska-Ziegler B; O'Connell MJ; Letvin NL
Cytometry; 1994 Sep; 17(1):102-8. PubMed ID: 8001455
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of a dual-color flow cytometry immunophenotyping panel in a multicenter quality assurance program.
Schenker EL; Hultin LE; Bauer KD; Ferbas J; Margolick JB; Giorgi JV
Cytometry; 1993; 14(3):307-17. PubMed ID: 8472607
[TBL] [Abstract][Full Text] [Related]
19. Flow cytometric immunophenotyping of lymphocyte subsets in samples that contain a high proportion of non-lymphoid cells.
Pattanapanyasat K; Kyle DE; Tongtawe P; Yongvanitchit K; Fucharoen S
Cytometry; 1994 Dec; 18(4):199-208. PubMed ID: 7534676
[TBL] [Abstract][Full Text] [Related]
20. Leukoflow: multiparameter extended white blood cell differentiation for routine analysis by flow cytometry.
van de Geijn GJ; van Rees V; van Pul-Bom N; Birnie E; Janssen H; Pegels H; Beunis M; Njo T
Cytometry A; 2011 Sep; 79(9):694-706. PubMed ID: 21786418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
